Towards Pharma 4.0 in clinical trials: A future-orientated perspective.

Area of Science:

• Pharmaceutical Sciences
• Health Informatics
• Biotechnology

Background:

• Pharma 4.0, inspired by Industry 4.0, integrates advanced technologies into drug development.
• Existing conceptualizations of Pharma 4.0 lack clear definitions, particularly in clinical trial applications.
• Traditional drug development faces challenges in aligning product quality with market speed.

Purpose of the Study:

• To define and propose a framework for integrating Pharma 4.0 technologies in the clinical trial stage.
• To analyze the impact and identify barriers to implementing this Pharma 4.0 framework.
• To explore future research applications and potential of Pharma 4.0 in clinical research.

Main Methods:

• Review of current computerized technologies used in clinical research.
• Development of a conceptual framework for Pharma 4.0 integration in clinical trials.
• Analysis of potential impacts and barriers associated with the proposed framework.

Main Results:

• Identification of key merged computerized technologies relevant to Pharma 4.0 clinical trials.
• A proposed framework for integrating Pharma 4.0 technologies into the clinical trial process.
• Discussion of the significant impacts and challenges in adopting this framework.

Conclusions:

• The proposed Pharma 4.0 framework offers a pathway to optimize clinical trials.
• Addressing identified barriers is crucial for successful implementation and realizing potential benefits.
• Further research is needed to explore the full scope of Pharma 4.0 applications in drug development.